Lung Cancer (EarlyCDT)

The EarlyCDT blood test measures your antibody response to 7 proteins produced by lung cancer cells. This can help find lung cancer at an early stage, before symptoms appear.

Sample
Blood
Collection
Venous draw at local venue
Results in
3–8 days
Biomarkers
1
Doctor reviewed
No
Tests for
  • EarlyCDT-Lung autoantibody panel

Test specifications

Sample type
blood
Collection method
venous draw at local venue
Turnaround time
3–8 days
Biomarkers tested
1
At-home test
No
Doctor reviewed
No
Gender focus
Both

What's tested

1 biomarker as listed by Bluecrest Wellness.

  • EarlyCDT-Lung autoantibody panel

About this test

The EarlyCDT blood test measures your antibody response to 7 proteins produced by lung cancer cells. This can help find lung cancer at an early stage, before symptoms appear.

The Lung Cancer (EarlyCDT) blood test checks for autoantibodies linked to lung cancer. These autoantibodies can appear before symptoms develop, helping to identify lung cancer at an early stage when treatment is more effective.

Our private Lung Cancer (EarlyCDT) test is a quick, easy, and accurate way to assess lung cancer risk. It can be added as an individual test to any of our existing packages.

Explore our packages and book online today. BOOK NOW

What is a Lung Cancer (EarlyCDT) test?

The Lung Cancer (EarlyCDT) test measures your immune response to seven proteins made by lung cancer cells. Your result is reported as low, moderate, or high risk.

If your result is moderate or high, further investigation with your GP is recommended.

Description provided by Bluecrest Wellness.

Our editorial score

Compare Health Test Score
Editorial confidence: 10.0/10

Score breakdown

  • Clarity and documentation 9.0/10

    The listing publishes a detailed description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.

  • Clinical depth 6.4/10

    1 biomarkers, placing it in the 32nd percentile of cancer screening tests we track.

  • Collection convenience 3.0/10

    Requires a venous draw at a clinic; results in around 8 days.

  • Results and follow-up 3.0/10

    Results are not doctor-reviewed as standard.

  • Trust signals 9.5/10

    Trustpilot 4.7 from 6,787 reviews; accredited lab (UKAS ISO 15189 own lab); CQC registered; trading 14+ years.

  • Value for money 2.0/10

    £299.00 against a median of £75.00 for the 19 similarly sized cancer screening tests we track (+299%).

View all →

qFIT Bowel Cancer Screening Test

A stool test using the qFIT method to measure blood in a stool sample, giving a numerical result rather than a simple positive or negative. Suited to adults wanting to check a common early indicator of possible bowel cancer risk.

  • At-home test
8.1 / 10 Priced close to the FIT test group median